Nutritional status and postoperative outcome after pneumonectomy for lung cancer.

P. Bagan,P. Berna,F. de Dominicis,João Carlos das Neves Pereira,P. Mordant,B. De La Tour,F. Le Pimpec-Barthes,M. Riquet

DOI: https://doi.org/10.1016/j.athoracsur.2012.06.023

2013-02-01

Abstract:

What problem does this paper attempt to address?

The Sulfur Microbial Diet and Risk of Nonalcoholic Fatty Liver Disease: a Prospective Gene–diet Study from the UK Biobank

Zhening Liu,Hangkai Huang,Jiaqi Ruan,Zejun Wang,Chengfu Xu

DOI: https://doi.org/10.1016/j.ajcnut.2023.11.012

IF: 8.472

2024-01-01

American Journal of Clinical Nutrition

Abstract:Background: The gut microbiota is closely related to liver diseases. The dietary pattern associated with sulfur -metabolizing bacteria in stool has been found to influence intestinal health. Objective: We aimed to investigate whether consuming the sulfur microbial diet is associated with nonalcoholic fatty liver disease (NAFLD). Methods: We included 143,918 participants of European descent from the UK Biobank. Information on serving sizes used per diet component was recorded by an online 24-h dietary assessment tool (Oxford WebQ). The total sulfur microbial diet score was constructed by summing the product of beta-coefficients and corresponding serving sizes. NAFLD was ascertained using hospital inpatient and death records. Cox proportional hazard models were used to estimate the adjusted hazard ratio (HR) and 95% confidence interval (CI). Mediation analyses were used to investigate underlying mediators including body mass index, waist circumference, glucose, triglyceride, urate, and C -reactive protein. A polygenic risk score for NAFLD was constructed and stratified to assess whether the association is modified by genetic predisposition. Results: After a median follow-up of 11.7 y (interquartile range: 11.3-12.5 y), we documented 1540 incident cases of NAFLD. After adjustment for covariates, we observed an overall J -shaped relationship between the sulfur microbial diet and risk of NAFLD. Those in the highest quartile of sulfur microbial diet score had a 46% increased risk of NAFLD [HRQ4vsQ1 (95% CI): 1.46 (1.26, 1.69)]. We also found that this association is partly mediated by metabolic disorders and systemic inflammation. In addition, the positive association was stronger among individuals at higher genetic risk for NAFLD (Pinteraction 1/4 0.044). Conclusions: The sulfur microbial diet had adverse associations with incident NAFLD, particularly in those at a higher genetic risk. Our study may provide evidence on the role of sulfur -metabolizing bacteria in the diet-NAFLD association.
Associations of Cumulative Exposure to Metal Mixtures with Metabolic Dysfunction-Associated Fatty Liver Disease in a Chinese Aged Population

Fanjia Guo,Lin Meng,Yaoyao Lin,Mingjuan Jin,Jianbing Wang,Mengling Tang,Kun Chen

DOI: https://doi.org/10.1289/isee.2022.p-0074

2022-01-01

ISEE Conference Abstracts

Abstract:BACKGROUND AND AIM: Few studies have demonstrated the potential effects of metal mixtures on metabolic dysfunction-associated fatty liver disease (MAFLD). Here, we examined the associations between whole blood metal mixtures and prevalence of MAFLD among an aged population in China. METHODS: a cross-sectional study of community-dwelling elderly adults were conducted in China. Whole blood concentrations of fourteen metals were measured by inductively coupled plasma mass spectrometry (ICP-MS). MAFLD was ascertained based on ultrasonographic evidence of hepatic steatosis and the presence of overweight/obesity, type 2 diabetes mellitus, or metabolic dysregulation. We performed logistic regression and restricted cubic spline (RCS) models to independently estimate the associations between metal concentrations and MAFLD prevalence. Environmental Risk Score (ERS) constructed by adaptive elastic net (AENET) and Bayesian kernel machine regression (BKMR) analysis were utilized to examine joint effects of metal mixtures and metal interactions on MAFLD. RESULTS: In the models adjusting for multiple covariates, lower blood copper and higher selenium, iron and mercury were significantly associated with the elevated prevalence of MAFLD. Non-linear effects of copper, iron, magnesium, manganese and selenium on MAFLD were observed in RCS models. Similar metals (copper, selenium, zinc, iron, cadmium and mercury) were selected as crucial predictors for MAFLD prevalence by AENET and BKMR models. The association between ERS and MAFLD was estimated and the ERS was significantly associated with the elevated OR for MAFLD. CONCLUSIONS: Our findings provide evidence that exposure to blood copper, iron, selenium and mercury are associated with the prevalence of MAFLD. Multiple metals exposure may adversely affect MAFLD, with copper, selenium, zinc, iron, cadmium and mercury being the major contributors. Further researches are needed to clarify the cumulative effects of metal mixture in a larger population. KEYWORDS: Metals; Mixture; Metabolic dysfunction-associated fatty liver disease; ERS; BKMR analysis
Clinical relevance of environmental manganese exposure with liver stiffness and steatosis detected by transient elastography in adults

Xiaohui Liu,Hong Shen,Mingfeng Chen,Jun Shao

DOI: https://doi.org/10.1007/s11356-021-17012-5

Abstract:Global manganese pollution to air and water is a significant threat to human health. The associations between manganese and liver stiffness and steatosis have not been reported in epidemiological studies. This study aimed to explore the clinical relevance of blood manganese with liver stiffness and steatosis in adults from the 2017-2018 National Health and Nutrition Examination Survey (N = 4,192). Subjects with excessive alcohol consumption and hepatitis B or C infection were excluded. Liver stiffness and steatosis were detected by transient elastography. Logistic regression and restricted cubic splines were adopted to explore the non-linear dose-response relationships. In multivariate analysis, while higher blood manganese concentrations were not associated with liver stiffness in the total sample and in males, an increased odds of significant liver fibrosis was found with higher blood manganese concentrations (tertile 3 vs. tertile 1) in females [odds ratios (95% confidence intervals): 2.34 (1.32-4.14), P trend < 0.01] and in other races [1.47 (1.05-2.05), P trend = 0.03]. Higher blood manganese concentrations were associated with liver steatosis in the total sample [1.33 (1.04-1.70), P trend = 0.03], in females [1.58 (1.02-2.44), P trend = 0.04], in other races [1.91 (1.50-2.43), P trend < 0.01], and in obese subjects [2.29 (1.13-4.65), P trend = 0.02]. Dose-response analysis showed that the departures from non-linear relationships between blood manganese concentrations and significant liver fibrosis (Pnon-linearity = 0.30) and steatosis (Pnon-linearity = 0.47) were not significant, suggesting that the observed associations were linear. In conclusion, higher blood manganese concentrations were positively associated with liver stiffness and steatosis, and the associations were mainly observed in females, in races other than Non-Hispanic White, and in obese subjects.
Low serum manganese as a noninvasive marker predicting the presence of myosteatosis among hospitalized patients with cirrhosis

Xuqian Zhang,Wanting Yang,Gaoyue Guo,Wetian Liu,Chao Sun

DOI: https://doi.org/10.1016/j.nutres.2024.04.001

IF: 3.876

2024-05-06

Nutrition Research

Abstract:Emerging evidence expands on a close connection between trace elements and muscular abnormalities, mostly focusing on sarcopenia. We hypothesized an association between concentrations of serum trace elements and myosteatosis, given that myosteatosis has a more pronounced clinical implication relative to sarcopenia, but there is a paucity of data in patients with cirrhosis. Consecutive patients were hospitalized for cirrhosis-associated complications. Serum trace elements (zinc, copper, manganese [Mn], magnesium, calcium, and iron) were measured by inductively coupled plasma mass spectrometry. The presence of myosteatosis was defined according to computed tomography–demarcated intramuscular adipose tissue content. In total, the 295 patients with cirrhosis analyzed had a median age of 63 years and 53.6% were male. Among them, 42 patients presented with myosteatosis (14.2%) and concomitant higher Model for End-stage Liver Disease-Sodium and triglyceride concentrations and lower neutrophil counts and serum Mn concentrations (all P < .05). No differences were found regarding other 5 trace elements in patients with versus without myosteatosis. The median serum Mn concentrations were 1.16 μg/L, and this population was categorized into high-Mn and low-Mn groups. The proportion of myosteatosis was significantly lower in high-Mn group than that in low-Mn group (8.1% vs 20.4%, P < .001). Univariable binary logistic regression indicated that low Mn was associated with myosteatosis (odds ratio, 2.906; 95% confidence interval, 1.424–5.932; P = .003) in the context of cirrhosis. This result was validated according to multivariable analysis by adjusting for confounding factors. In conclusion, low serum Mn can be predictive of myosteatosis, a novel muscular abnormality representing more clinical relevance and close relation to inferior outcomes among cirrhosis.

nutrition & dietetics
Iron Status and NAFLD among European Populations: A Bidirectional Two-Sample Mendelian Randomization Study

Cenqin Liu,Yishu Chen,Zhixin Zhang,Jiarong Xie,Chaohui Yu,Lei Xu,Youming Li

DOI: https://doi.org/10.3390/nu14245237

IF: 5.9

2022-01-01

Nutrients

Abstract:Background and aim: Previous observational studies have suggested a paradoxical relationship between iron status and the risk of non-alcoholic fatty liver disease (NAFLD). Observed associations in these epidemiological studies fail to show sequential temporality and suffer from problems of confounding. Therefore, we performed a bidirectional two-sample Mendelian randomization (MR) to evaluate the relationship between serum iron status and NAFLD. Methods: The inverse weighted method (IVW) meta-analysis with the fixed-effect model was the main method to estimate the relationship between iron status, including serum ferritin, iron, transferrin saturation (TSAT) and total iron-binding capacity (TIBC), and NAFLD. Weighted median, penalized weighted median, and MR Robust Adjusted Profile Score (MR RAPS) methods were used as additional analyses. Sensitivity analyses were performed with Cochran's Q test, MR-Egger regression, Steiger filtering, and the MR PRESSO test. Results: Iron status, including serum ferritin, iron, and TSAT, was associated with an increased risk of NAFLD (odds ratio (OR) (95% confidence interval (CI)): 1.25 (1.06, 1.48); 1.24 (1.05, 1.46), 1.16 (1.02, 1.31), respectively). In contrast, minimal effects of NAFLD on serum ferritin, iron, TSAT, and TIBC were observed (OR (95% CI): 1.01 (1.00, 1.02), 1.01 (1.00, 1.02), 1.03 (1.01, 1.05), 1.03 (1.01, 1.05), respectively). Conclusions: Our findings corroborated the causal associations between serum ferritin, iron, TSAT, and NAFLD, which might suggest the potential benefits of iron-related therapy. In addition, NAFLD might, in turn, slightly affect iron homeostasis indicated as serum ferritin, iron, TSAT, and TIBC, but this needs to be further confirmed.
Blood manganese and nonalcoholic fatty liver disease: A cohort-based case-control study

Di Zhang,Shouling Wu,Yanqi Lan,Shuohua Chen,Yanhong Wang,Yuanyuan Sun,Wei Liao,Li Wang

DOI: https://doi.org/10.1016/j.chemosphere.2021.132316

IF: 8.8

2022-01-01

Chemosphere

Abstract:Background & aimsAs both a toxic and essential trace element in humans, limited research focuses on the association between blood manganese (Mn) and nonalcoholic fatty liver disease (NAFLD). We aimed to assess blood Mn concentration and its relationship with NAFLD among adults in Northern China.MethodsWe conducted a cohort-based case-control study among 1816 patients with NAFLD (970 males and 846 females) and 1111 healthy controls (598 males and 513 females). We used the restricted cubic splines method to investigate the potential non-linear relationship and logistic regression models to analyze the association between blood Mn and NAFLD.ResultsThe median (p25, p75) of blood Mn concentration in males was 10.08 (8.42,11.98) μg/L, higher than that in females [9.79 (8.01,12.04)] μg/L, P = 0.011. Compared with the tertile 1 group of Mn in males, the odds ratio (95 % confidence interval) of NAFLD for tertile 2 and tertile 3 group was 0.82 (0.61,1.10) and 0.64 (0.47,0.87), respectively. The reverse correlation was consistent in patients with different fibrosis severity determined by fibrosis-4 score. The protective association was more evident in those with triglycerides ≥1.7 mmol/L [odds ratio (95 % confidence interval) of tertile 3 vs. tertile 1: 0.40 (0.22,0.75)]. We found a non-significant U-shaped relationship between Mn and NAFLD in women.ConclusionThere may exist sex differences for the association between blood Mn and NAFLD. Higher blood Mn may be a potential protective factor for NAFLD in males. The subjects with TG ≥ 1.7 mmol/L would benefit more from higher blood Mn levels.

environmental sciences
Blood Manganese and Non-Alcoholic Fatty Liver Disease in a High Manganese Exposure Area in China

Liping Wu,Yanqi Lan,Ze Yu,Yanhong Wang,Wei Liao,Guoqiang Zhang,Li Wang

DOI: https://doi.org/10.1186/s41043-023-00467-2

2023-01-01

Journal of Health Population and Nutrition

Abstract:Abstract Background and aims Manganese (Mn) deficiency and intoxication may affect nonalcoholic fatty liver disease (NAFLD) risk differently. We aimed to explore the association between blood Mn and NAFLD in an area with high Mn exposure in drinking water. Methods We conducted a case–control study among 1407 patients with NAFLD and 1774 sex- and age-matched healthy controls in a physical examination population in Zhoushan hospital, Zhejiang province in China. We used the restricted cubic splines method to investigate the dose–response relationship. Logistic regression models were applied to determine the risk of NAFLD, and severity of NAFLD. Results The blood Mn concentration was higher in the NAFLD group than in the control group in women (16.1 ± 6.2 μg/L vs. 14.7 ± 6.4 μg/L, P = 0.022) and men (14.5 ± 6.3 μg/L vs. 13.6 ± 6.8 μg/L, P < 0.001). We found an inverted L shape relationship between blood Mn and NAFLD in both women and men. Compared to the lowest quartile, the adjusted odds ratio (OR) and 95% confidence interval (CI) of NAFLD for the highest quartile group was 1.646(1.222,2.217), 1.494(1.082,2.061), and 3.146(1.285,7.701) for the total population, men, and women. The positive relationship was only observed in those with fibrosis-4 score < 1.30 and normal alanine transaminase. Stratified analysis showed an interaction between smoking (P = 0.073), alcohol drinking (P = 0.013), and Mn, with a more prominent effect on the NAFLD in the never-smokers (OR = 2.153, 95% CI 1.408–3.290) and drinkers (OR = 2.596, 95% CI 1.608–4.191). Conclusion Higher blood Mn is associated with an elevated NAFLD risk in the high Mn exposure areas, especially in nonsmokers and drinkers. Further studies are needed to verify this result in the areas with high Mn exposure.
280-OR: Manganese Regulates Hepatic Insulin Sensitivity and Glucose Tolerance

JENNIFER GAMARRA,YUKE XIE,SEI HIGUCHI,REBECCA HAEUSLER

DOI: https://doi.org/10.2337/db24-280-or

IF: 7.7

2024-06-14

Diabetes

Abstract:Introduction & Objective: Metals are known to be necessary for cellular processes such as signal transduction and in protein conformation, though the characterization of which proteins bind metals is incomplete. Manganese (Mn) is known to be required for life but is one of the least understood metals. We aim to: (i) determine the mechanisms that regulate Mn and (ii) the molecular targets of Mn. Methods: We used a mouse model of Mn excess that depletes the Mn efflux transporter, Slc30a10, from the liver and intestine (Slc30a10Tbg,Vil). We conducted metabolic studies on mice kept on a standard chow diet or fed a high-fat diet for eight weeks. We used primary hepatocytes treated with Mn ex vivo to perform glucose production assays and assess the phosphorylation cascade in the insulin signaling pathway. Results: We found that Slc30a10Tbg,Vil mice have a significant improvement in glucose tolerance on a standard chow diet and are protected from impaired glucose tolerance when put on a high-fat diet. We treated hepatocytes with Mn ex vivo and found a significant reduction in glucose production. These data were associated with increased phosphorylation of Akt targets without increased phosphorylation of Akt itself. Using knockout and inhibitor approaches, we found that Mn acts downstream of both insulin receptor and PI3 kinase, suggesting that Mn acts directly on Akt. Fasting and refeeding studies on wildtype mice found Slc30a10 is low during fasting and increases rapidly after refeeding. Conclusions: These data suggest Mn acts directly on Akt to sensitize hepatocytes to insulin. Further, our finding that Slc30a10 is regulated nutritionally suggests the possibility that controlled access to Mn may be a physiological mechanism to regulate Akt activity. These results highlight a novel role of Mn in the insulin signaling pathway and shed light on how Mn homeostasis is regulated in the liver. Disclosure J. Gamarra: None. Y. Xie: None. S. Higuchi: None. R. Haeusler: None.

endocrinology & metabolism
Associations Between Genetically Proxied Inhibition of Lipid-Lowering Drug Targets and Serum Micronutrients among Individuals of European Descent: A Mendelian Randomization Study

Jing-Yang He,Xue Zhang,Kui Wang,Wan-Qiang Lv

DOI: https://doi.org/10.1093/jn/nxac012

IF: 4.735

2022-01-01

Journal of Nutrition

Abstract:Background: Limited and inconclusive data exist concerning the associations between lipid-lowering drugs and serum micronutrient concentrations. Methods: We conducted Mendelian randomization (MR) analyses to explore the associations between lipid-lowering drug targets and serum micronutrients. Single-nucleotide polymorphisms in genes encoding molecular targets of LDL cholesterol-lowering therapies were selected as instrumental variables for 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGCR; target of statins), proprotein convertase subtilisin/kexin type 9 (PCSK9; target of PCSK9 inhibitors), and Niemann-Pick C1-Like 1 (NPC1L1; target of ezetimibe). Exposure data were extracted from a published genome-wide association study (GWAS) of lipids in 188,577 European individuals, with outcome data obtained from the Integrative Epidemiology Unit (IEU) GWAS database (). Overall, age and sex information were not calculable from the summary-level GWAS data. MR analyses were performed using the inverse-variance weighted method and MR sensitivity analysis methods. Results: We found genetically proxied inhibition of HMGCR to lower iron (effect, -0.16; 95% CI: -0.27, -0.06; P value = 0.003), zinc (effect, -0.83; 95% CI: -1.36, -0.31; P value = 0.002), magnesium (effect, -0.17; 95% CI: -0.27, -0.06; P value = 0.003), potassium (effect, -0.17; 95% CI: -0.27, -0.06; P value = 0.002), genetically proxied inhibition of NPC1L1 to increase calcium (effect, 0.28; 95% CI: 0.10, 0.46; P value = 0.003), retinol (effect, 0.25; 95% CI: 0.07, 0.44; P value = 0.01), and genetically proxied inhibition of PCSK9 to increase vitamin D (effect, 0.10; 95% CI: 0.07, 0.12; P value = 1.8 x 10(-19)). These associations were robust in MR sensitivity analyses. However, the associations between genetically proxied inhibition of HMGCR and NPC1L1 and the micronutrients were not consistent in multiple comparisons. Conclusions: Our results provide evidence that statin use may lower serum concentrations of iron, zinc, magnesium, and potassium, PCSK9 inhibitors may increase serum vitamin D, and ezetimibe may increase serum calcium and retinol concentrations.
Association Between Blood Manganese Levels and Visceral Adipose Tissue in the United States: A Population-Based Study

Chengzhe Tao,Yuna Huang,Xuzhao Huang,Zhi Li,Yun Fan,Yan Zhang,Tingya Wan,Liyu Lu,Qiaoqiao Xu,Wei Wu,Di Wu,Feng Zhang,Chuncheng Lu

DOI: https://doi.org/10.3390/nu14224770

IF: 5.9

2022-01-01

Nutrients

Abstract:Background: Manganese (Mn) is an essential trace element with a narrow toxic margin for human health. The association between Mn exposure and adverse visceral adipose tissue (VAT) accumulation is unclear. Objective: This study aimed to estimate the associations of blood Mn levels with VAT mass or visceral obesity in the general population in the United States. Method: This cross-sectional study included data of 7297 individuals released by National Health and Nutrition Examination Survey (NHANES). VAT was quantified with dual-energy X-ray absorptiometry, and blood Mn was measured using inductively coupled plasma mass spectrometry. The generalized linear model and generalized additive model (GAM) were applied to estimate the linear and non-linear associations between Mn levels and VAT mass, respectively. Logistic regression was used to estimate the associations between blood Mn levels and the risk of visceral obesity. Results: Fully adjusted generalized linear regression revealed that individuals in the higher quantile of Mn had increased VAT mass compared with those in the lower quantile (β per quantile change = 0.025; 95% CI of 0.017, 0.033; p < 0.001). Positive associations were also observed in males and females (males: β per quantile change = 0.012, 95% CI of 0.002, 0.022 (p = 0.020); female: β per quantile change = 0.036; 95% CI of 0.023, 0.048 (p < 0.001)). The GAM illustrated that the non-linear associations between blood Mn levels and VAT mass were in U-shape patterns (effective degree of freedom >1 in total participants, males, and females). A stratified analysis found significant interactions between Mn and the family income-to-poverty ratio (PIR) in males, with stronger associations in males with a PIR < 1.3 (β = 0.109; 95% CI of 0.048, 0.170). Additional analyses revealed that individuals in the highest quantile of Mn had a 39% higher risk of visceral obesity (OR = 1.39; 95% CI of 1.15–1.69; p < 0.001). Conclusions: Higher blood Mn levels were positively associated with increased VAT mass and visceral obesity risk. The adverse VAT phenotype associated with excessive blood Mn levels should be further investigated.
Associations between blood and urinary manganese with metabolic syndrome and its components: Cross-sectional analysis of National Health and Nutrition Examination Survey 2011–2016

Kenneth Lo,Jing-Li Yang,Chao-Lei Chen,Lin Liu,Yu-Qing Huang,Ying-Qing Feng,Ai-Min Yang

DOI: https://doi.org/10.1016/j.scitotenv.2021.146527

2021-08-01

Abstract:Manganese (Mn) may improve cardiometabolic health with its anti-oxidative ability. However, epidemiological evidence on the overall and sex-specific relationship between Mn exposure and metabolic syndrome (MetS) has been inconclusive. We evaluated the associations of urinary (n = 1713) and blood (n = 3335) Mn levels with the prevalence of MetS, its components (elevated waist circumference, impaired glucose metabolism, elevated blood pressure and dyslipidemia) and sex-dependent heterogeneities among participants in the United States National Health and Nutrition Examination Survey 2011–2016. After adjusting for multiple covariates and the levels of other metals (Arsenic, Barium, Cadmium, Mercury, Molybdenum, Tin and Uranium), urinary Mn at the third quartile associated with a lower odd of MetS (odds ratio [OR] = 0.55, 95% confidence interval [C.I.] = 0.32–0.97), elevated waist circumference (OR = 0.56, 95% C.I. = 0.36–0.86) and elevated fasting plasma glucose (OR = 0.46, 95% C.I. = 0.27–0.76) among overall participants, and lower odds of MetS (OR = 0.40, 95% C.I. = 0.16–0.99), elevated waist circumference (OR = 0.39, 95% C.I. = 0.19–0.81) and elevated fasting plasma glucose (OR = 0.44, 95% C.I. = 0.22–0.90) among men. The U-shaped dose-response relationship between urinary Mn and MetS (P non-linear = 0.008) was observed among all participants. We did not observe the significant associations of blood Mn with the prevalence of MetS. Compared with other metals, urinary Mn played a less important role in development of MetS (posterior inclusion probabilities [PIP] = 0.49 for Mn versus 0.54 to 0.91 for other metals), but the contribution of blood Mn (PIP = 0.59 versus 0.60 to 0.61) was similar to other blood metals (Cadmium, Lead, Mercury and Selenium). These findings have provided new evidence of the potential roles of Mn in cardiometabolic health, and the needs to explore how Mn interacts with multiple metals in sex-specific manner.

environmental sciences
Cotinine exposure enhances the association of blood manganese and non-alcoholic fatty liver disease in American children: a cross-sectional study

Li-ping Zhang,Hua-xing Wei,Shi-hui Lin,Bin-wei Qiu,Jin-liang Lin

DOI: https://doi.org/10.1038/s41598-024-75298-0

IF: 4.6

2024-10-19

Scientific Reports

Abstract:This cross-sectional survey aims to determine whether cotinine exposure would enhance the relationship between blood manganese (Mn) and non-alcoholic fatty liver disease (NAFLD) in children using the NHANES database. Restricted cubic spline (RCS) and logistic regression analyses were adopted to determine the potential relationship. Besides, we tested the robustness of the results by performing trend tests and subgroup analyses. The study finally enrolled 866 children aged 18 years and below. Blood Mn was linearly linked to NAFLD and the risk of NAFLD was increased with the blood Mn elevation ( P < 0.05). There was a notable relationship between blood Mn and NAFLD in crude model 1, which was still significant upon adjustment of all the identified covariates (all P < 0.05). Under Mn exposure, the cotinine-exposed group had a higher risk of NAFLD than the cotinine-unexposed group. In conclusion, blood Mn level is an independent risk factor for pediatric NAFLD, and cotinine exposure can enhance this relationship to some degree. Therefore, reducing cotinine exposure may alleviate detrimental consequences related to exposure to heavy metals in children.

multidisciplinary sciences
Genetically determined circulating micronutrients and the risk of nonalcoholic fatty liver disease

Ke Liu,Ying Chen,Jiaxin Chen,Weiwei Chen,Xiaohui Sun,Yingying Mao,Ding Ye

DOI: https://doi.org/10.1038/s41598-024-51609-3

IF: 4.6

2024-01-12

Scientific Reports

Abstract:Evidence from epidemiological literature on the association of circulating micronutrients with risk of nonalcoholic fatty liver disease (NAFLD) is inconsistent. We aimed to elucidate the causal relationships using Mendelian randomization (MR). Single-nucleotide polymorphisms associated with 14 circulating micronutrients (β-carotene, calcium, copper, folate, iron, magnesium, phosphorus, selenium, vitamin B6, B12, C, D, K1 and zinc) were employed as instrumental variables. Summary level data for NAFLD were obtained from a genome-wide association study (GWAS) meta-analysis of 8434 cases and 770,180 controls (discovery stage) and another two datasets including 1483 NAFLD cases and 17,781 controls (replication stage 1) and 2134 NAFLD cases and 33,433 controls (replication stage 2). Inverse variance-weighted method (IVW) was used as primary analysis, supplemented with a series of sensitivity analysis. Genetically predicted higher β‐carotene levels were suggestively associated with reduced NAFLD risk [odds ratio (OR) 0.81, 95% confidence interval (CI) 0.66–0.99; P = 0.047], whereas the association did not survive the false discovery rates (FDR) correction ( P FDR = 0.164). Genetically predicted circulating iron (OR 1.16, 95% CI 1.05–1.29; P = 0.006, P FDR = 0.028), selenium (OR 1.11, 95% CI 1.03–1.20; P = 0.005, P FDR = 0.028) and vitamin B12 (OR 1.08, 95% CI 1.03–1.13; P = 0.002, P FDR = 0.028) were significantly associated with increased risk of NAFLD. Moreover, the findings were consistent in individual datasets ( P heterogeneity > 0.05) and confirmed in sensitivity analysis. Our study provided evidence that circulating iron, selenium and vitamin B12 might be causally linked to the risk of NAFLD, which deserves further exploration of the potential biological mechanism.

multidisciplinary sciences
Causes of obesity: Looking beyond the hypothalamus

A. Peters,L. Pellerin,M. Dallman,K. Oltmanns,U. Schweiger,J. Born,H. Fehm

DOI: https://doi.org/10.1016/j.pneurobio.2006.12.004

IF: 10.885

2007-02-01

Progress in Neurobiology

Abstract:
Intra-abdominal pressure changes during natural movements in man.

S. Grillner,J. Nilsson,A. Thorstensson

DOI: https://doi.org/10.1111/J.1748-1716.1978.TB06215.X

1978-07-01

Acta Physiologica Scandinavica

Abstract:The weight of the upper part of the trunk is partially transmitted to the pelvis via the vertebral column. If the muscle walls around the abdominal cavity are contracted, a high pressure can be generated within the cavity (greater than 200 mmHg). The abdominal space can them transmit part of weight to, e.g., the upper part of the body, Intra-abdominal pressure recordings have been performed during locomotion and other natural movements with intragastric pressure recordings. With each step, there is a phasic variation in pressure, with its peak coinciding with that of the peak vertical force exerted by the leg against the ground. The peak values increase progressively with the speed of walking/running up to a mean of 38 mmHg and with trough values of 16 mmHg. The phasic variations with each step is due to a phasic activation of the abdominal muscles, with an EMG activity starting 50 ms or more before foot contact. If an extra load is put on the back, the posture changes and at the highest speed of running the pressure values are significantly higher than without this additional load. After a jump down from a moderate height of 0.4 m, the average increase is 89 mmHg and can often exceed 100 mmHg. These pressure changes are large and will presumably act to unload the spine under the prevailing biomechanical conditions and, in addition, there will no doubt be an effect on the circulatory system.
Apoptosis-associated generation of reactive oxygen intermediates and release of pro-inflammatory cytokines in human lymphocytes and granulocytes by extracts from the seeds of Acalypha wilkesiana.

A. Büssing,G. Stein,I. Herterich-Akinpelu,U. Pfüller

DOI: https://doi.org/10.1016/S0378-8741(98)00227-X

IF: 5.195

1999-09-01

Journal of Ethnopharmacology

Abstract:
Manganese induces podocyte injury through regulating MTDH/ALKBH5/NLRP10 axis: Combined analysis at epidemiology and molecular biology levels

Qiuju Liang,Jiajun Jing,Huiming He,Xiaofeng Huang,Jianing Liu,Mingjun Wang,Zijuan Qi,Li'e Zhang,Ziang Huang,Yuanliang Yan,Sijin Liu,Ming Gao,Yunfeng Zou

DOI: https://doi.org/10.1016/j.envint.2024.108672

Abstract:Manganese (Mn) is an essential micronutrient required for various biological processes but excess exposure to Mn can cause neurotoxicity. However, there are few reports regarding the toxicity effect of Mn on the kidney as well as the underlying molecule mechanism. Herein, in vivo experiments were adopted to assess the toxicity effects associated with Mn, and found that chronic Mn treatment induced the injury of glomerular podocytes but not renal tubule in rats. Genome-wide CRISPR/Cas9 knockout screen was then employed to explore the biotargets of the toxic effect of Mn on podocytes. Through functional analyses of the enriched candidate genes, NLRP10 was found to be significantly up-regulated and mediated Mn-induced podocyte apoptosis. Further mechanism investigation revealed that NLRP10 expression was regulated by demethylase AlkB homolog 5 (ALKBH5) in an m6A-dependent fashion upon Mn treatment. Moreover, Mn could directly bind to Metadherin (MTDH) and promoted its combination with ALKBH5 to promote NLRP10 expression and cell apoptosis. Finally, logistic regressions, restricted cubic spline regressions and uniform cubic B-spline were used to investigate the association between Mn exposure and the risk of chronic kidney disease (CKD). A U-shaped nonlinear relationship between CKD risk and plasma Mn level, and a positive linear relationship between CKD risk and urinary Mn levels was found in our case-control study. To sum up, our findings illustrated that m6A-dependent NLRP10 regulation is indispensable for podocyte apoptosis and nephrotoxicity induced by Mn, providing fresh insight into understanding the health risk of Mn and a novel target for preventing renal injury in Mn-intoxicated patients.
Dietary pattern modifies the risk of MASLD through metabolomic signature

Hanzhang Wu,Jiahe Wei,Shuai Wang,Liangkai Chen,Jihui Zhang,Ningjian Wang,Xiao Tan

DOI: https://doi.org/10.1016/j.jhepr.2024.101133

2024-06-10

Abstract:Background & aims: The EAT-Lancet Commission in 2019 advocated a plant-centric diet for health and environmental benefits, but its relation to metabolic dysfunction-associated steatotic liver disease (MASLD) is unclear. We aimed to discover the metabolite profile linked to the EAT-Lancet diet and its association with MASLD risk, considering genetic predisposition. Methods: We analyzed data from 105,752 UK Biobank participants with detailed dietary and metabolomic information. We constructed an EAT-Lancet diet index and derived a corresponding metabolomic signature through elastic net regression. A weighted polygenic risk score for MASLD was computed from associated risk variants. The Cox proportional hazards model was employed to estimate hazard ratios (HRs) and 95% CIs for the risk of MASLD (defined as hospital admission or death). Results: During a median follow-up period of 11.6 years, 1,138 cases of MASLD were documented. Participants in the highest group for the EAT-Lancet diet index had a multivariable HR of 0.79 (95% CI 0.66-0.95) for MASLD compared to the lowest group. The diet's impact was unaffected by genetic predisposition to MASLD (p = 0.42). Moreover, a robust correlation was found between the metabolomic signature and the EAT-Lancet diet index (Pearson r = 0.29; p <0.0001). Participants in the highest group for the metabolomic signature had a multivariable HR of 0.46 (95% CI 0.37-0.58) for MASLD, in comparison to those in the lowest group. Conclusions: Higher intake of the EAT-Lancet diet and its associated metabolite signature are both linked to a reduced risk of MASLD, independently of traditional risk factors. Impact and implications: Our analysis leveraging the UK Biobank study showed higher adherence to the EAT-Lancet diet was associated with a reduced risk of metabolic dysfunction-associated steatotic liver disease (MASLD). We identified a unique metabolite signature comprising 81 metabolites associated with the EAT-Lancet diet, potentially underlying the diet's protective mechanism against MASLD. These findings suggest the EAT-Lancet diet may offer substantial protective benefits against MASLD.
Do iron homeostasis biomarkers mediate the associations of liability to type 2 diabetes and glycemic traits in liver steatosis and cirrhosis: a two-step Mendelian randomization study

Ying Liang,Shan Luo,Steven Bell,Jacky Man Yuen Mo,Baoting He,Yangzhong Zhou,Xiaoyin Bai,Shiu Lun Au Yeung

DOI: https://doi.org/10.1186/s12916-024-03486-w

IF: 9.3

2024-06-26

BMC Medicine

Abstract:Abstract Background Previous studies, including Mendelian randomization (MR), have demonstrated type 2 diabetes (T2D) and glycemic traits are associated with increased risk of metabolic dysfunction-associated steatotic liver disease (MASLD). However, few studies have explored the underlying pathway, such as the role of iron homeostasis. Methods We used a two-step MR approach to investigate the associations of genetic liability to T2D, glycemic traits, iron biomarkers, and liver diseases. We analyzed summary statistics from various genome-wide association studies of T2D ( n = 933,970), glycemic traits ( n ≤ 209,605), iron biomarkers ( n ≤ 246,139), MASLD ( n ≤ 972,707), and related biomarkers (alanine aminotransferase (ALT) and proton density fat fraction (PDFF)). Our primary analysis was based on inverse-variance weighting, followed by several sensitivity analyses. We also conducted mediation analyses and explored the role of liver iron in post hoc analysis. Results Genetic liability to T2D and elevated fasting insulin (FI) likely increased risk of liver steatosis (OR liability to T2D : 1.14 per doubling in the prevalence, 95% CI: 1.10, 1.19; OR FI : 3.31 per log pmol/l, 95% CI: 1.92, 5.72) and related biomarkers. Liability to T2D also likely increased the risk of developing liver cirrhosis. Genetically elevated ferritin, serum iron, and liver iron were associated with higher risk of liver steatosis (OR ferritin : 1.25 per SD, 95% CI 1.07, 1.46; OR liver iron : 1.15 per SD, 95% CI: 1.05, 1.26) and liver cirrhosis (OR serum iron : 1.31, 95% CI: 1.06, 1.63; OR liver iron : 1.34, 95% CI: 1.07, 1.68). Ferritin partially mediated the association between FI and liver steatosis (proportion mediated: 7%, 95% CI: 2–12%). Conclusions Our study provides credible evidence on the causal role of T2D and elevated insulin in liver steatosis and cirrhosis risk and indicates ferritin may play a mediating role in this association.

medicine, general & internal
AN IMMUNOCHEMICAL STUDY OF THE PROTEINS IN CEREBROSPINAL FLUID

F. Rosenthal,J. Soothill

DOI: https://doi.org/10.1136/jnnp.25.2.177

1962-05-01

Journal of Neurology Neurosurgery & Psychiatry

Abstract:Quantitative gel diffusion precipitin techniques make possible rapid estimation of a wide range of serum proteins. We report a study of cerebrospinal fluid proteins using such a technique. The cerebrospinal fluid: serum concentration ratios for seven serum proteins were determined in patients investigated for a wide range of neurological disease.

Nutritional status and postoperative outcome after pneumonectomy for lung cancer.

The Sulfur Microbial Diet and Risk of Nonalcoholic Fatty Liver Disease: a Prospective Gene–diet Study from the UK Biobank

Associations of Cumulative Exposure to Metal Mixtures with Metabolic Dysfunction-Associated Fatty Liver Disease in a Chinese Aged Population

Clinical relevance of environmental manganese exposure with liver stiffness and steatosis detected by transient elastography in adults

Low serum manganese as a noninvasive marker predicting the presence of myosteatosis among hospitalized patients with cirrhosis

Iron Status and NAFLD among European Populations: A Bidirectional Two-Sample Mendelian Randomization Study

Blood manganese and nonalcoholic fatty liver disease: A cohort-based case-control study

Blood Manganese and Non-Alcoholic Fatty Liver Disease in a High Manganese Exposure Area in China

280-OR: Manganese Regulates Hepatic Insulin Sensitivity and Glucose Tolerance

Associations Between Genetically Proxied Inhibition of Lipid-Lowering Drug Targets and Serum Micronutrients among Individuals of European Descent: A Mendelian Randomization Study

Association Between Blood Manganese Levels and Visceral Adipose Tissue in the United States: A Population-Based Study

Associations between blood and urinary manganese with metabolic syndrome and its components: Cross-sectional analysis of National Health and Nutrition Examination Survey 2011–2016

Cotinine exposure enhances the association of blood manganese and non-alcoholic fatty liver disease in American children: a cross-sectional study

Genetically determined circulating micronutrients and the risk of nonalcoholic fatty liver disease

Causes of obesity: Looking beyond the hypothalamus

Intra-abdominal pressure changes during natural movements in man.

Apoptosis-associated generation of reactive oxygen intermediates and release of pro-inflammatory cytokines in human lymphocytes and granulocytes by extracts from the seeds of Acalypha wilkesiana.

Manganese induces podocyte injury through regulating MTDH/ALKBH5/NLRP10 axis: Combined analysis at epidemiology and molecular biology levels

Dietary pattern modifies the risk of MASLD through metabolomic signature

Do iron homeostasis biomarkers mediate the associations of liability to type 2 diabetes and glycemic traits in liver steatosis and cirrhosis: a two-step Mendelian randomization study

AN IMMUNOCHEMICAL STUDY OF THE PROTEINS IN CEREBROSPINAL FLUID